Smoking cessation pharmacotherapy among smokers hospitalized for coronary heart disease

Quinn R. Pack*, Aruna Priya, Tara C. Lagu, Penelope S. Pekow, Nancy A. Rigotti, Peter K. Lindenauer

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

11 Scopus citations
Original languageEnglish (US)
Pages (from-to)1525-1527
Number of pages3
JournalJAMA internal medicine
Volume177
Issue number10
DOIs
StatePublished - Oct 2017

Funding

Funding/Support: Dr Pack was supported by award No. KL2TR001063 from the National Center for Advancing Translational Sciences of the National Institutes of Health (NIH). Dr Lagu was supported by award No. K01HL114745 from the National Heart, Lung, and Blood Institute (NHLBI) of the NIH. Dr Rigotti was supported by award No. 1R01HL11821 from the NHLBI of the NIH. Dr Lindenauer was supported by award No. 1K24HL132008 from the NHLBI of the NIH. Role of the Funder/Sponsor: The funding sources had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. 1. Rigotti NA, Clair C, Munafò MR, Stead LF. Interventions for smoking cessation in hospitalised patients. Cochrane Database Syst Rev. 2012;(5):CD001837. 2. Fiore MC, Adsit R. Will hospitals finally “do the right thing”? providing evidence-based tobacco dependence treatments to hospitalized patients who smoke. Jt Comm J Qual Patient Saf. 2016;42(5):207-208. Conflict of Interest Disclosures: Dr Rigotti receives royalties from UpToDate for smoking cessation chapters, has received a research grant from Pfizer, and has consulted without honorarium for Pfizer regarding smoking cessation. All other authors report no conflicts of interest.

ASJC Scopus subject areas

  • Internal Medicine

Cite this